A Clinical Study of Maxillary Sinus Squamous Cell Carcinoma.

Authors :: Kondo A
Kurose M
Obata K
Yamamoto K
Murayama K
Shirasaki H
Himi T
Source :: Advances in oto-rhino-laryngology [Adv Otorhinolaryngol] 2016; Vol. 77, pp. 83-7. Date of Electronic Publication: 2016 Apr 26.
Publication Year :: 2016
Abstract: We report a retrospective study of 26 patients with maxillary sinus squamous cell carcinoma who were treated at the Sapporo Medical University between January 2002 and December 2008. The 5-year local control rate was 85.7% in patients with stage T2-3 disease and 61.0% in patients with stage T4a disease. The overall 5-year survival rate was 71.3% and the 5-year disease-specific survival rate was 79.9%. The 5-year disease-specific survival rate was 100% in patients with T2-3 disease and 44.4% in patients with T4 disease. The 5-year disease-specific survival rate was 76.3% in patients with N0 disease and 87.5% in patients with N+ disease. Five patients died of stage T4a disease. Two died of uncontrolled tumors at the primary site and 3 patients died of lung metastasis. We should consider another approach for the treatment of patients with advanced maxillary sinus carcinoma in the future.<br /> (© 2016 S. Karger AG, Basel.)